A detailed history of Martingale Asset Management L P transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 47,077 shares of SAGE stock, worth $256,098. This represents 0.01% of its overall portfolio holdings.

Number of Shares
47,077
Previous 30,360 55.06%
Holding current value
$256,098
Previous $329,000 3.04%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.02 - $13.08 $117,353 - $218,658
16,717 Added 55.06%
47,077 $339,000
Q2 2024

Aug 12, 2024

BUY
$10.58 - $17.9 $118,665 - $200,766
11,216 Added 58.59%
30,360 $329,000
Q1 2024

May 14, 2024

BUY
$18.62 - $26.95 $18,620 - $26,950
1,000 Added 5.51%
19,144 $358,000
Q4 2023

Feb 12, 2024

BUY
$17.1 - $22.26 $310,262 - $403,885
18,144 New
18,144 $393,000
Q1 2023

May 12, 2023

BUY
$37.27 - $46.57 $630,384 - $787,684
16,914 New
16,914 $709,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.